A detailed history of Legacy Wealth Asset Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Legacy Wealth Asset Management, LLC holds 2,176 shares of BIIB stock, worth $347,790. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,176
Previous 2,090 4.11%
Holding current value
$347,790
Previous $484,000 13.02%
% of portfolio
0.13%
Previous 0.15%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$189.07 - $236.8 $16,260 - $20,364
86 Added 4.11%
2,176 $421,000
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $17,527 - $21,778
92 Added 4.6%
2,090 $484,000
Q1 2024

Apr 19, 2024

BUY
$212.02 - $267.71 $16,325 - $20,613
77 Added 4.01%
1,998 $430,000
Q4 2023

Jan 10, 2024

SELL
$222.59 - $267.94 $2,225 - $2,679
-10 Reduced 0.52%
1,921 $497,000
Q3 2023

Oct 31, 2023

BUY
$253.3 - $285.89 $8,105 - $9,148
32 Added 1.69%
1,931 $496,000
Q2 2023

Aug 04, 2023

SELL
$275.25 - $318.06 $550,500 - $636,120
-2,000 Reduced 51.3%
1,899 $540,000
Q1 2023

Apr 21, 2023

SELL
$256.56 - $292.34 $12,058 - $13,739
-47 Reduced 1.19%
3,899 $1.08 Million
Q4 2022

Feb 02, 2023

SELL
$252.44 - $306.72 $37,108 - $45,087
-147 Reduced 3.59%
3,946 $1.09 Million
Q3 2022

Oct 14, 2022

BUY
$194.69 - $268.46 $158,477 - $218,526
814 Added 24.82%
4,093 $1.09 Million
Q2 2022

Jul 19, 2022

BUY
$187.54 - $223.02 $13,127 - $15,611
70 Added 2.18%
3,279 $669,000
Q1 2022

May 12, 2022

BUY
$193.77 - $244.14 $79,833 - $100,585
412 Added 14.73%
3,209 $676,000
Q4 2021

Feb 10, 2022

BUY
$223.92 - $287.77 $66,280 - $85,179
296 Added 11.84%
2,797 $671,000
Q3 2021

Oct 19, 2021

BUY
$282.99 - $369.05 $3,678 - $4,797
13 Added 0.52%
2,501 $708,000
Q2 2021

Jul 14, 2021

BUY
$259.0 - $414.71 $21,238 - $34,006
82 Added 3.41%
2,488 $862,000
Q1 2021

Apr 20, 2021

BUY
$242.95 - $284.63 $18,950 - $22,201
78 Added 3.35%
2,406 $673,000
Q4 2020

Mar 25, 2021

BUY
$236.26 - $355.63 $550,013 - $827,906
2,328 New
2,328 $570,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $23B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Legacy Wealth Asset Management, LLC Portfolio

Follow Legacy Wealth Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Wealth Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Wealth Asset Management, LLC with notifications on news.